CD24-Fc Reduces Inflammation and Improves T Cell Function in HIV-Infected Mice
Author Information
Author(s): Li Guangming, Ma Jianping, Yu Haisheng, Tsahouridis Ourania, Lou Yaoxian, He Xiuting, Funaki Masaya, Mathur Poonam, Kottilil Shyamasundaran, Zheng Pan, Liu Yang, Su Lishan
Primary Institution: Institute of Human Virology, University of Maryland School of Medicine
Hypothesis
Can CD24-Fc treatment reduce inflammation and improve T cell function in HIV-infected humanized mice undergoing cART?
Conclusion
CD24-Fc treatment significantly reduces inflammation and improves the recovery of CD8 T cells in HIV-infected humanized mice.
Supporting Evidence
- CD24-Fc treatment resolved residual inflammation in HIV-infected mice.
- CD24-Fc improved the recovery of CD4 and CD8 T cells.
- Treatment with CD24-Fc delayed HIV-1 rebound after cART cessation.
- CD24-Fc enhanced the functionality of HIV-specific T cells.
Takeaway
This study shows that a special protein called CD24-Fc can help reduce inflammation and make immune cells work better in mice with HIV.
Methodology
The study used humanized mice infected with HIV-1 and treated them with CD24-Fc alongside cART to assess inflammation and immune response.
Limitations
The specific cell types targeted by CD24-Fc remain unclear, and the study was conducted in a mouse model, which may not fully replicate human responses.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website